Showing 2,221 - 2,240 results of 103,675 for search '(( a step decrease ) OR ( 5 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.50s Refine Results
  1. 2221

    Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

    Published 2015
    “…Here, we synthesize a library of poly­(3-hexyl­thiophene) (P3HT) <i>block</i> poly­((9,9-dialkyl­fluorene)-2,7-diyl-<i>alt</i>-[4,7-bis­(alkyl­thiophen-5-yl)-2,1,3-benzo­thiadiazole]-2′,2″-diyl) (PFTBT) donor-<i>block</i>-acceptor all-conjugated block copolymers and carry out a comprehensive study of processing conditions, crystallinity, domain sizes, and side-chain structure on photovoltaic device performance. …”
  2. 2222
  3. 2223

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    “…<div><p>HIV acquisition risk with norethisterone (NET) enanthate (NET-EN) is reportedly less than for depo-medroxyprogesterone acetate intramuscular (DMPA-IM). We investigated the effects of these progestin-only injectable contraceptives on serum testosterone and sex hormone binding globulin (SHBG) levels, since these may play a role in sexual behavior and HIV acquisition. …”
  4. 2224
  5. 2225

    Investigating the shared genetics of non-syndromic cleft lip/palate and facial morphology by Laurence J. Howe (5579186)

    Published 2018
    “…Across 5,804 individuals of European ancestry from two studies, we found strong evidence, using PRS, of genetic overlap between nsCL/P and philtrum width; a 1 S.D. increase in nsCL/P PRS was associated with a 0.10 mm decrease in philtrum width (95% C.I. 0.054, 0.146; P = 2x10<sup>-5</sup>). …”
  6. 2226
  7. 2227
  8. 2228
  9. 2229
  10. 2230
  11. 2231

    A New Rotane Family:  Synthesis, Structure, Conformation, and Dynamics of [3.4]-, [4.4]-, [5.4]-, and [6.4]Rotane<sup>1</sup> by Lutz Fitjer (2466634)

    Published 1998
    “…This is the highest barrier of inversion ever reported for a cyclohexane. Promising candidates for even higher barriers are [6.5]rotane (<b>32</b>) and [6.6]rotane (<b>33</b>).…”
  12. 2232
  13. 2233

    Design and analysis of PV fed high-voltage gain DC-DC converter using PI and NN controllers by Madisa V.G., Varaprasad

    Published 2022
    “…When the converter switch comes under active state two capacitors are discharged in series, similarly when the converter switch under inactive state those two capacitors are charged in parallel through the coupled inductor (CI) energy so, to get a high voltage at the converter output side. To reuse the leakage-inductor (LI) energy of the CI with the help of a passive clamp circuit for reducing the voltage stress across the switch, similarly switch has less resistance so conduction losses also decreased. …”
    Get full text
    Get full text
    Get full text
    article
  14. 2234

    Possible model of AVT system in mate-guarding, aggressive and courtship behaviors. by Saori Yokoi (430681)

    Published 2015
    “…(D) The homozygote <i>V1a2</i> mutant males exhibited decreased courtship displays and low aggression (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005009#pgen.1005009.g004" target="_blank">Figs. 4A and 4B</a>). …”
  15. 2235

    Effect of the AVT system on mate-guarding behavior. by Saori Yokoi (430681)

    Published 2015
    “…<p>(A) Manning compound injection decreased the guarding index. …”
  16. 2236

    Image_1_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Background<p>Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear.</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  17. 2237

    Image_4_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Background<p>Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear.</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  18. 2238

    Image_6_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Background<p>Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear.</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  19. 2239

    Image_2_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Background<p>Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear.</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  20. 2240

    Image_7_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Background<p>Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear.</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”